530119 NATRAJPR

Natraj Proteins Share Price

₹46.35 +3.14 (7.27%)

22 Nov, 2024 21:26

SIP TrendupStart SIP in NATRAJPR

Start SIP

Performance

  • Low
  • ₹0
  • High
  • ₹0
  • 52 Week Low
  • ₹0
  • 52 Week High
  • ₹0
  • Open Price₹0
  • Previous Close₹0
  • Volume0

Investment Returns

  • Over 1 Month -4.92%
  • Over 3 Month + 0.76%
  • Over 6 Month -8.15%
  • Over 1 Year -0.22%
SIP Lightning

Smart Investing Starts Here Start SIP with Natraj Proteins for Steady Growth!

Invest Now

Natraj Proteins Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

Natraj Proteins Financials

Natraj Proteins Technicals

EMA & SMA

Current Price
₹46.35
+ 3.14 (7.27%)
pointer
  • stock-down_img
  • Bullish Moving Average 6
  • stock-up_img
  • Bearish Moving Average 10
  • 20 Day
  • ₹46.28
  • 50 Day
  • ₹47.25
  • 100 Day
  • ₹47.79
  • 200 Day
  • ₹48.18

Resistance and Support

45.06 Pivot Speed
  • R3 49.96
  • R2 48.15
  • R1 46.87
  • S1 43.78
  • S2 41.97
  • S3 40.69

What's your outlook on Natraj Proteins?

You can only vote for once

Natraj Proteins Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-09 Quarterly Results
2024-08-13 Quarterly Results
2024-05-27 Audited Results
2024-02-10 Quarterly Results
2023-11-03 Quarterly Results

Natraj Proteins F&O

Natraj Proteins Shareholding Pattern

No data available.

About Natraj Proteins

  • NSE Symbol
  • NATRAJPR
  • BSE Symbol
  • 530119
  • ISIN
  • INE444D01016

Similar Stocks to Natraj Proteins

Natraj Proteins FAQs

Natraj Proteins share price is ₹46 As on 22 November, 2024 | 21:12

The Market Cap of Natraj Proteins is ₹17.4 Cr As on 22 November, 2024 | 21:12

The P/E ratio of Natraj Proteins is -4.9 As on 22 November, 2024 | 21:12

The PB ratio of Natraj Proteins is 0.5 As on 22 November, 2024 | 21:12

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91
 
footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23